Lexaria Receives Three Patent Grants and Two Notices of Allowance; Provides Patent Portfolio Guidance

Kelowna, British Columbia /TheNewswire /September 7, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces strategic additions to its patent portfolio.   Three new Australian patents were granted to Lexaria by theAustralian Patent Office,bringing theCompany’s worldwide patent portfolio to eight issued patents:four each in the […]